Dr. Rachel Tate uptoTate
8 years ago
PET CT protocol with high NPV (98%)could be used as a first-line test to rule out GCA vs bx. https://t.co/yQEyQyHcDx @RheumNow #ACR18 L15
Jose Campos JoseCamposMD
8 years ago
2828 Utility of Fecal Calprotectin Levels for the Diagnosis of Inflammatory Bowel Disease in Patients with Spondylorarthritis #ACR18 https://t.co/QUPgiwT1dt
As expected, this year’s ACR meeting saw an upswing in the number of abstracts on immune related adverse events from checkpoint inhibitor therapy compared to last year. With the increase in approved indications for checkpoint inhibitors (CPIs), rheumatologists everywhere are going to be getting referrals for rheumatic irAEs.
Suleman Bhana, MD DrBhana
8 years ago
Dr. Polly Ferguson
SAPHO dx criteria, Kahn 2003
including
-bone /joint involvement with psoriasis
-bone joint with severe acne
-isolated steroid hyperostosis/osteeitis
-CRMO (children)
-bone-joint with IBD
excluding:
-bone tumor
-non inflammatory
#ACR18 @RheumNow
Emily Littlejohn ELittlejohnDO
8 years ago
Common patient concern: Humira and pregnancy.
IgG does not cross the placenta until 12-15 weeks. Consider discontinuing in late second trimester or early third trimester to avoid high serum drug concentrations in the newborn 🤰🏻 #ACR18 #CleClinicRheum
Suleman Bhana, MD DrBhana
8 years ago
Dr. Kavanaugh: Abstract 826.
https://t.co/X0MKvAO3UV
Does Anti-Glomerular Basement (anti-GBM) Antibody Positivity Correlate with Relapse in Patients with Anti-GBM Disease? —Presence of ANCA predicts relapse. #ACR18 @RheumNow
Suleman Bhana, MD DrBhana
8 years ago
Dr. Cush
ABSTRACT 898
Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial —missed RSSS outcome, but improved lung function #ACR18 @Rheumnow
https://t.co/E7LdBEfXWc
Suleman Bhana, MD DrBhana
8 years ago
Dr. Kavanaugh: Abstract 1068.
Role of Cannabinoid CB2 Receptor Agonist, in IL-1β-Induced Inflammation in RA Synovial Fibroblasts —CB2 therapeutic target
#ACR18 @RheumNow
https://t.co/fZoPnLKQcjβ-induced-inflammation-in-human-rheumatoid-arthr…
Suleman Bhana, MD DrBhana
8 years ago
Dr. Cush
abstract 428
Significant Pain Reduction with Oral Methotrexate in Knee Osteoarthritis; Results from a Randomised Controlled Phase III Trial of Treatment Effectiveness —improved pain but not clinically meaningful
#ACR18 @Rheumnow
https://t.co/S9wHaKjDLB
Suleman Bhana, MD DrBhana
8 years ago
Dr. Kavanaugh
Highlighting a Session: ACR Immunology update
B Cell directed therapy, Dr. R. John Looney from Rochester, NY
“Next Generation of B Cell and Plasma Cell Therapies” —looking for new targeted therapies
#ACR18 @RheumNow
Suleman Bhana, MD DrBhana
8 years ago
Dr. Kavanaugh
ABSTRACT: 1234
Incidence of Conversion of Screening Tests for TB (PPD, GIF-release assay) in Patients Treated with TNF-α Inhibitors —small no. of patients converted but in higher risk patients
https://t.co/k6nRyIGGlUα-inhibitors/
#ACR18 @RheumNow
Dr. Erin Tree DrTinyTree
8 years ago
#Rheum roundup gives highlights from Reproductive Guidelines, draft presented at #ACR18:
-Ask early and often about pregnancy and contraception. These are important conversations.
-No MTX, leflunomide, CYC, MMF in pregnancy
-Healthy mom➡️healthy baby
Suleman Bhana, MD DrBhana
8 years ago
Dr. Kavanaugh
Abstract 1175
(no link)
Sweedish study: ETA biosimilar rx habits and prices. Biosimilar usage increases until originator med price drops, then biosimilar usage drops
#ACR18 @RheumNow
Suleman Bhana, MD DrBhana
8 years ago
Dr. Cush
ABSTRACT: 2220
Gout, Flares and Allopurinol Use: A Population Based Study. —Australian study, large number of under treated with rate lowering therapy. Also, see abstracts: 1247, 1272. #ACR18 @Rheumnow
https://t.co/BJKqxFtuvG
Suleman Bhana, MD DrBhana
8 years ago
Dr. Kavanaugh
ABSTRACT: 404
Interleukin 17A– a Translational Target to Treat Supraspinatus Tendinopathy —found high IL17A in human SS tendinopathy. Then rodent model, IL17A blockade improves tendon structure/function
#ACR18 @Rheumnow
https://t.co/wa8R9UBplR
